GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,761.00p
   
  • Change Today:
      27.50p
  • 52 Week High: 1,767.50
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.92m
  • Volume: 14,302,691
  • Market Cap: £72,992m
  • RiskGrade: 129

Regulatory News

Director/PDMR Shareholding 22-Feb-2024 15:30 RNS
ViiV LAI superior to orals in adherence-challenged 21-Feb-2024 07:00 RNS
Julie Brown - External Appointment 20-Feb-2024 09:01 RNS
Director/PDMR Shareholding 19-Feb-2024 15:30 RNS
Director/PDMR Shareholding 15-Feb-2024 15:32 RNS
GSK completes acquisition of Aiolos Bio 15-Feb-2024 07:00 RNS
Director/PDMR Shareholding - Replacement 13-Feb-2024 16:45 RNS
Director/PDMR Shareholding 13-Feb-2024 15:40 RNS
Director/PDMR Shareholding 13-Feb-2024 15:35 RNS
Director/PDMR Shareholding 13-Feb-2024 15:30 RNS
FDA accepts Arexvy filing for adults 50-59 at risk 06-Feb-2024 07:10 RNS
Shingrix 18+ at risk China filing review accepted 06-Feb-2024 07:05 RNS
GSK presents positive DREAMM-7 phase III data 06-Feb-2024 07:00 RNS
Director/PDMR Shareholding 01-Feb-2024 15:30 RNS
Total Voting Rights 01-Feb-2024 15:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,761.00p
Change Today 27.50p
% Change 1.59 %
52 Week High 1,767.50
52 Week Low 1,316.00
Volume 14,302,691
Shares Issued 4,144.92m
Market Cap £72,992m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
25.74% above the market average25.74% above the market average25.74% above the market average25.74% above the market average25.74% above the market average
68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average68.63% above the sector average
Price Trend
49.19% above the market average49.19% above the market average49.19% above the market average49.19% above the market average49.19% above the market average
70.91% above the sector average70.91% above the sector average70.91% above the sector average70.91% above the sector average70.91% above the sector average
Income
8.79% above the market average8.79% above the market average8.79% above the market average8.79% above the market average8.79% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
22.96% below the market average22.96% below the market average22.96% below the market average22.96% below the market average22.96% below the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 07-May-2024

Time Volume / Share Price
16:36 605,610 @ 1,761.00p
16:36 605,610 @ 1,761.00p
11:30 2,800,000 @ 1,736.00p
11:30 2,800,000 @ 1,736.00p
16:47 18,589 @ 1,762.54p

GSK Key Personnel

CEO Emma Walmsley

Top of Page